Switching natalizumab to cladribine: A monocentric observational trial in multiple sclerosis

Authors
Category Primary study
Conference12th Congress of the European Academy of Neurology
Year 2026
This article has no abstract
Epistemonikos ID: 6df70eb56f2d6cdd12af0ae74b574c8f78699aae
First added on: Sep 12, 2026